THE US FDA has approved
Levemir (insulin detemir [rDNA
origin] injection) for use in children
aged 2-5 years with type 1 diabetes.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 23 May 12 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 12
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.